South Korea's Minister of Health and Welfare Cho Kyu-hong said at a press conference on the 8th local time that after comprehensively considering the suggestions of frontline interns and the situation on the front line of medical care, the government decided that from that day on, all interns and residents who resigned would not be given administrative sanctions such as revoking their medical licenses. Cho Kyu-hong also said that for interns and residents who have returned to work and those who have resigned and are preparing to re-register for internship courses in September, the government will make special cases to try to minimize the internship gap and not affect the relevant doctors from obtaining specialist medical licenses. Cho Kyu-hong said that the government believes that in order to minimize the diagnosis and treatment gaps for critically ill and emergency patients and ensure the smooth training process of interns and residents, it is in the public interest, so it has made a decision not to punish interns and residents who resigned. It is hoped that major hospitals will complete the resignation processing of doctors who have not returned to work before July 15 and determine the scale of vacancies. Previously, large general hospitals in South Korea, such as Seoul National University Hospital, Yonsei University Severance Hospital, and Seoul Asan Medical Center, suspended or limited their medical services in an effort to cancel all penalties against interns and residents.

A provocative new study reveals the complex effects of the space environment on human health, providing insight into potential damage to blood, cell structure and the immune system. The study focused on SpaceX's Inspiration4 mission, which successfully sent two men and two women into space in 2021 to orbit the Earth for three days and shed some light on the effects of space travel on the human body. The research data, derived directly from the Inspiration4 mission, shows that even a brief trip to space can significantly damage the human immune system, trigger an inflammatory response, and profoundly affect cell structure. In particular, space travel triggered unprecedented changes in cytokines that play a key role in immune response and muscle regulation but are not usually directly associated with inflammation. In particular, the study found a significant increase in muscle factors, which are physiological responses specific to skeletal muscle cells in microgravity, rather than a simple immune response. Although non-muscular tissues did not show changes in proteins associated with inflammation, specific leg muscles such as soleus and tibialis anterior muscles showed significant signs of metabolic activity, especially increased interleukin in the latter, further enhancing the activation of immune cells.

McDonald's China, together with its four major suppliers announced the launch of an industrial park in Xiaogan city, Central China's Hubei Province on Wednesday, highlighting the importance of Chinese market in terms of supply chain for food business. With a combined investment of 1.5 billion yuan ($206 million), the park, named Hubei Smart Food Industrial Park, is a joint project with Bimbo QSR, XH Supply Chain, Tyson Foods Inc, and Zidan, according to information provided to the Global Times. The park is expected to produce 34,000 tons of meat products, 270 million buns, 30 million pastries, and 2 billion packaged products annually. It also features a 25,000-square-meter high-standard automated warehouse for frozen, refrigerated, and dry goods, reducing logistics time by 90 percent from manufacturing to arriving at the destination. Leveraging local geographical advantages, the park will become a supply hub for McDonald's in central and western China, enhancing supply efficiency and stability for its outlets there, the company said. "McDonald's has been deeply rooted in China for over 30 years, and the park is an echo of our long-term development in China," said Phyllis Cheung, CEO of McDonald's China. "Without any long-term strategy, we don't have any structural advantage in China," Cheung noted. The US food giant continues to expand its business map in China. As of the end of June in 2024, there were over 6,000 restaurants and over 200,000 employees in the market. China has become the second largest and fastest-growing market of McDonald's. In 2023, McDonald's China unveiled the ambition of operating 10,000 restaurants by 2028. To support this, McDonald's and its suppliers have invested over 12 billion yuan from between 2018 to 2023 to develop new production capacities and enhance supply chain sustainability. Observers said that the industrial park reflect foreign companies' confidence in operating in China as the country takes concrete measures in furthering reform and opening-up. China's foreign direct investment from January to May 2024 reached 412.51 billion yuan, with the number of newly-established foreign-backed companies reaching 21,764, rising by 17.4 percent year-on-year, data from China's Ministry of Commerce revealed. According to a recent survey by the American Chamber of Commerce in China, the majority of US companies saw improved profitability in China in 2023, and half of the survey participants put China as their first choice or within their top three investment destinations globally. Olaf Korzinovski, EVP of Volkswagen China, who is responsible for production and components, also shared his understanding of supply chains in China with the Global Times. Volkswagen has been operating in China for about 40 years. "In order to seize greater value for our customers," Volkswagen Group is stepping up pace of innovation in China, and systematically purshing forward the digitalization process, Korzinovski noted, adding the company is strengthening local capabilities with accelerated decision-making efficiency. Global Times

The returner of the Chang'e-6 lunar probe is opened during a ceremony at the China Academy of Space Technology under the China Aerospace Science and Technology Corporation in Beijing, capital of China, June 26, 2024. The returner of the Chang'e-6 lunar probe was opened at a ceremony in Beijing on Wednesday afternoon. During the ceremony at the China Academy of Space Technology under the China Aerospace Science and Technology Corporation, researchers opened the returner and examined key technical indicators. Photo: Xinhua As the US space industry recently faced yet more delays and stagnation with key components including manned spacecraft and space suits "going wrong," NASA has once again resorted to its "sour grapes" rhetoric upon seeing China's successful retrieval of fresh lunar soils from the far side of the moon, by claiming that China did not directly invite its scientists to participate in the lunar soil research. This behavior is a typical blame-shifting trick, Chinese experts said, noting it is clear to all that it is the US' own laws, not China, that are restricting space cooperation between the two sides. Instead of deceiving themselves by distorting the truth, the US should face up to its own problem of overall weakening engineering capability and the lack of long-term planning in its space industry. After the Chang'e-6 samples, weighing nearly 2 kilograms, were safely transported to a special laboratory for further study on Friday, NASA spokesperson Faith McKie told media that while China worked with the European Space Agency, France, Italy and Pakistan on this mission, "NASA wasn't invited to take part in the moon probe." NASA also didn't get "any direct invitation" to study China's moon rocks, after it welcomed all scientists from around the world to apply to study them, McKie told NatSec Daily. Responding to the remarks, Chinese Foreign Ministry spokesperson Mao Ning told the Global Times on Monday that China is open to having space exchanges with the US, and we also welcome countries around the world to take part in the study of lunar samples. "However, the US side seems to have forgotten to mention its domestic legislation such as the Wolf Amendment. The real question is whether US scientists and institutions are allowed by their own government to participate in cooperation with China," Mao said. "The existence of the Wolf Amendment has basically shut the door to space collaboration between the two countries," Wang Yanan, chief editor of Beijing-based Aerospace Knowledge magazine, told the Global Times on Monday. Even if research institutions of the US have the willingness to work with China on opportunities such as lunar sample research, institutions there must obtain special approval from the US Congress due to the presence of this amendment, Wang explained. Currently, no such "green light" is in sight from the Congress. Furthermore, China's collaboration with international partners is based on equality and mutual benefit, leveraging their respective scientific resources, facilities, and expertise. However, the US only wants what it doesn't have, and its engagement with China would be advantageous only to itself, Wang noted. NASA has found itself embroiled in a number of thorny issues recently, with the latest being Boeing's Starliner manned spaceship experiencing both helium leaks and thruster issues during a June 6 docking with the International Space Station (ISS), which led to an indefinite delay for its crew's return to Earth, despite NASA's insistence that they are not "stranded" in space. The return of the Starliner capsule, while has already been delayed by two weeks, will be put on hold "well into the summer" pending results of new thruster tests, which are scheduled to start Tuesday and will take approximately two weeks or even more, per NASA officials. Previously on June 24, NASA cancelled a spacewalk on the ISS following a "serious situation," when one of the spacesuits experienced coolant leak in the hatch. While being broadcast on a livestream, the astronauts reported "literally water everywhere" as they were preparing for the extravehicular activity, space.com reported. The report said that this is the second time this particular spacewalk was postponed, after a June 13 attempt with a different astronaut group was pushed back due to a "spacesuit discomfort." The recurring issues with the spacesuits are due to their much-extended service lifespan, media reported, as the puffy white ones US astronauts currently wear were designed more than 40 years ago. Despite the pressing need to replace them, NASA announced recently that it is abandoning a plan to develop next-generation spacesuits, which had been committed to be delivered by 2026, CNN reported on Thursday. One of the root causes for such problems is that the US has developed many large technology conglomerates, which for a long time have benefited significantly from government orders and industry monopolies. Consequently, in many complex engineering fields, the level of attention given is greatly insufficient, Wang noted. It also reflected the US' lack of long-term strategic planning for its manned space program. For instance, the ageing spacesuits should have been replaced a decade ago to ensure that operational suits remain in usable condition. Failure to address this issue results in a hindrance to the space station's necessary maintenance tasks and even poses life-threatening risks to astronauts in emergency situations, experts said. The issues with Boeing's spacecraft and the spacesuits are not isolated problems, but reflected a systemic issue in the US space industry - the overall weakening of engineering capabilities, they noted.

White House spokeswoman Karina Jean-Pierre denied a report in the U.S. media on the 8th that President Joseph Biden did not receive treatment for Parkinson's disease. Biden had the first televised debate of the 2024 presidential election with Republican opponent Donald Trump on June 27, and his poor performance on the spot triggered discussions about his physical condition. The New York Times reported that a doctor specializing in the treatment of Parkinson's disease had "visited" the White House eight times from August last year to March this year. Facing the media's questions about Biden's health, Jean-Pierre asked and answered himself at a regular White House press conference on the 8th: "Has the president received treatment for Parkinson's disease? No. Is he currently receiving treatment for Parkinson's disease? No, he is not. Is he taking medication for Parkinson's disease? No." Jean-Pierre said Biden had seen a neurologist three times, all related to his annual physical examination. She also took out the report issued by the doctor after Biden's most recent physical examination in February this year. The report said, "An extremely detailed neurological examination was once again reassuring" because no symptoms consistent with stroke, multiple sclerosis or Parkinson's disease were found. The doctor who went to the White House mentioned by the New York Times is Kevin Kanal, a neurology and movement disorder expert at the Walter Reed National Military Medical Center in Maryland and an authority on Parkinson's disease. Jean-Pierre suggested that the doctor might have come to treat military personnel on duty at the White House.